Selected research
Market Analysis & Forecast
Global Health Products for The Elderly Market Analysis and Forecast 2026-2032
Market perspective
The global Health Products for The Elderly market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Health Products for The Elderly is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Health Products for The Elderly is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Health Products for The Elderly is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Health Products for The Elderly is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Health Products for The Elderly include Amway, Blackmores Limited, Danone, Glanbia Plc, GNC Holdings, LLC, Herbalife Nutrition Ltd., Nestlé SA, Novartis and Suntory Holdings Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Health Products for The Elderly, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Health Products for The Elderly, also provides the revenue of main regions and countries. Of the upcoming market potential for Health Products for The Elderly, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Health Products for The Elderly revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Health Products for The Elderly market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Health Products for The Elderly revenue, projected growth trends, production technology, application and end-user industry.
Health Products for The Elderly Segment by Company
Amway
Blackmores Limited
Danone
Glanbia Plc
GNC Holdings, LLC
Herbalife Nutrition Ltd.
Nestlé SA
Novartis
Suntory Holdings Limited
USANA Health Sciences, Inc.
Bayer
Tongrentang
H&H Group
Xiamen Kindomway Group Company
Nestlé Health Science
By-health
PERFECT
INFINITUS
China New Era Group
Health Products for The Elderly Segment by Type
Nutritional Supplements
Vitamins and Minerals
Others
Health Products for The Elderly Segment by Application
Online Sales
Offline Sales
Health Products for The Elderly Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Health Products for The Elderly market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Health Products for The Elderly and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Health Products for The Elderly.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Health Products for The Elderly in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Health Products for The Elderly company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Health Products for The Elderly revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nutritional Supplements
- Vitamins and Minerals
- Others
Applications
- Online Sales
- Offline Sales
Companies covered
- Amway
- Blackmores Limited
- Danone
- Glanbia Plc
- GNC Holdings, LLC
- Herbalife Nutrition Ltd.
- Nestlé SA
- Novartis
- Suntory Holdings Limited
- USANA Health Sciences, Inc.
- Bayer
- Tongrentang
- H&H Group
- Xiamen Kindomway Group Company
- Nestlé Health Science
- By-health
- PERFECT
- INFINITUS
- China New Era Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Health Products for The Elderly Market by Type
- 1.2.1 Global Health Products for The Elderly Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Nutritional Supplements
- 1.2.3 Vitamins and Minerals
- 1.2.4 Others
- 1.3 Health Products for The Elderly Market by Application
- 1.3.1 Global Health Products for The Elderly Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Online Sales
- 1.3.3 Offline Sales
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Health Products for The Elderly Market Dynamics
- 2.1 Health Products for The Elderly Industry Trends
- 2.2 Health Products for The Elderly Industry Drivers
- 2.3 Health Products for The Elderly Industry Opportunities and Challenges
- 2.4 Health Products for The Elderly Industry Restraints
3 Global Growth Perspective
- 3.1 Global Health Products for The Elderly Market Perspective (2021-2032)
- 3.2 Global Health Products for The Elderly Growth Trends by Region
- 3.2.1 Global Health Products for The Elderly Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Health Products for The Elderly Market Size by Region (2021-2026)
- 3.2.3 Global Health Products for The Elderly Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Health Products for The Elderly Revenue by Players
- 4.1.1 Global Health Products for The Elderly Revenue by Players (2021-2026)
- 4.1.2 Global Health Products for The Elderly Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Health Products for The Elderly Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Health Products for The Elderly Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Health Products for The Elderly Key Players Headquarters & Area Served
- 4.4 Global Health Products for The Elderly Players, Product Type & Application
- 4.5 Global Health Products for The Elderly Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Health Products for The Elderly Market CR5 and HHI
- 4.6.3 2025 Health Products for The Elderly Tier 1, Tier 2, and Tier 3
5 Health Products for The Elderly Market Size by Type
- 5.1 Global Health Products for The Elderly Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Health Products for The Elderly Revenue by Type (2021-2032)
- 5.3 Global Health Products for The Elderly Revenue Market Share by Type (2021-2032)
6 Health Products for The Elderly Market Size by Application
- 6.1 Global Health Products for The Elderly Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Health Products for The Elderly Revenue by Application (2021-2032)
- 6.3 Global Health Products for The Elderly Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Amway
- 7.1.1 Amway Company Information
- 7.1.2 Amway Business Overview
- 7.1.3 Amway Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.1.4 Amway Health Products for The Elderly Product Portfolio
- 7.1.5 Amway Recent Developments
- 7.2 Blackmores Limited
- 7.2.1 Blackmores Limited Company Information
- 7.2.2 Blackmores Limited Business Overview
- 7.2.3 Blackmores Limited Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.2.4 Blackmores Limited Health Products for The Elderly Product Portfolio
- 7.2.5 Blackmores Limited Recent Developments
- 7.3 Danone
- 7.3.1 Danone Company Information
- 7.3.2 Danone Business Overview
- 7.3.3 Danone Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.3.4 Danone Health Products for The Elderly Product Portfolio
- 7.3.5 Danone Recent Developments
- 7.4 Glanbia Plc
- 7.4.1 Glanbia Plc Company Information
- 7.4.2 Glanbia Plc Business Overview
- 7.4.3 Glanbia Plc Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.4.4 Glanbia Plc Health Products for The Elderly Product Portfolio
- 7.4.5 Glanbia Plc Recent Developments
- 7.5 GNC Holdings, LLC
- 7.5.1 GNC Holdings, LLC Company Information
- 7.5.2 GNC Holdings, LLC Business Overview
- 7.5.3 GNC Holdings, LLC Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.5.4 GNC Holdings, LLC Health Products for The Elderly Product Portfolio
- 7.5.5 GNC Holdings, LLC Recent Developments
- 7.6 Herbalife Nutrition Ltd.
- 7.6.1 Herbalife Nutrition Ltd. Company Information
- 7.6.2 Herbalife Nutrition Ltd. Business Overview
- 7.6.3 Herbalife Nutrition Ltd. Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.6.4 Herbalife Nutrition Ltd. Health Products for The Elderly Product Portfolio
- 7.6.5 Herbalife Nutrition Ltd. Recent Developments
- 7.7 Nestlé SA
- 7.7.1 Nestlé SA Company Information
- 7.7.2 Nestlé SA Business Overview
- 7.7.3 Nestlé SA Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.7.4 Nestlé SA Health Products for The Elderly Product Portfolio
- 7.7.5 Nestlé SA Recent Developments
- 7.8 Novartis
- 7.8.1 Novartis Company Information
- 7.8.2 Novartis Business Overview
- 7.8.3 Novartis Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.8.4 Novartis Health Products for The Elderly Product Portfolio
- 7.8.5 Novartis Recent Developments
- 7.9 Suntory Holdings Limited
- 7.9.1 Suntory Holdings Limited Company Information
- 7.9.2 Suntory Holdings Limited Business Overview
- 7.9.3 Suntory Holdings Limited Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.9.4 Suntory Holdings Limited Health Products for The Elderly Product Portfolio
- 7.9.5 Suntory Holdings Limited Recent Developments
- 7.10 USANA Health Sciences, Inc.
- 7.10.1 USANA Health Sciences, Inc. Company Information
- 7.10.2 USANA Health Sciences, Inc. Business Overview
- 7.10.3 USANA Health Sciences, Inc. Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.10.4 USANA Health Sciences, Inc. Health Products for The Elderly Product Portfolio
- 7.10.5 USANA Health Sciences, Inc. Recent Developments
- 7.11 Bayer
- 7.11.1 Bayer Company Information
- 7.11.2 Bayer Business Overview
- 7.11.3 Bayer Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.11.4 Bayer Health Products for The Elderly Product Portfolio
- 7.11.5 Bayer Recent Developments
- 7.12 Tongrentang
- 7.12.1 Tongrentang Company Information
- 7.12.2 Tongrentang Business Overview
- 7.12.3 Tongrentang Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.12.4 Tongrentang Health Products for The Elderly Product Portfolio
- 7.12.5 Tongrentang Recent Developments
- 7.13 H&H Group
- 7.13.1 H&H Group Company Information
- 7.13.2 H&H Group Business Overview
- 7.13.3 H&H Group Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.13.4 H&H Group Health Products for The Elderly Product Portfolio
- 7.13.5 H&H Group Recent Developments
- 7.14 Xiamen Kindomway Group Company
- 7.14.1 Xiamen Kindomway Group Company Company Information
- 7.14.2 Xiamen Kindomway Group Company Business Overview
- 7.14.3 Xiamen Kindomway Group Company Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.14.4 Xiamen Kindomway Group Company Health Products for The Elderly Product Portfolio
- 7.14.5 Xiamen Kindomway Group Company Recent Developments
- 7.15 Nestlé Health Science
- 7.15.1 Nestlé Health Science Company Information
- 7.15.2 Nestlé Health Science Business Overview
- 7.15.3 Nestlé Health Science Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.15.4 Nestlé Health Science Health Products for The Elderly Product Portfolio
- 7.15.5 Nestlé Health Science Recent Developments
- 7.16 By-health
- 7.16.1 By-health Company Information
- 7.16.2 By-health Business Overview
- 7.16.3 By-health Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.16.4 By-health Health Products for The Elderly Product Portfolio
- 7.16.5 By-health Recent Developments
- 7.17 PERFECT
- 7.17.1 PERFECT Company Information
- 7.17.2 PERFECT Business Overview
- 7.17.3 PERFECT Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.17.4 PERFECT Health Products for The Elderly Product Portfolio
- 7.17.5 PERFECT Recent Developments
- 7.18 INFINITUS
- 7.18.1 INFINITUS Company Information
- 7.18.2 INFINITUS Business Overview
- 7.18.3 INFINITUS Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.18.4 INFINITUS Health Products for The Elderly Product Portfolio
- 7.18.5 INFINITUS Recent Developments
- 7.19 China New Era Group
- 7.19.1 China New Era Group Company Information
- 7.19.2 China New Era Group Business Overview
- 7.19.3 China New Era Group Health Products for The Elderly Revenue and Gross Margin (2021-2026)
- 7.19.4 China New Era Group Health Products for The Elderly Product Portfolio
- 7.19.5 China New Era Group Recent Developments
8 North America
- 8.1 North America Health Products for The Elderly Revenue (2021-2032)
- 8.2 North America Health Products for The Elderly Revenue by Type (2021-2032)
- 8.2.1 North America Health Products for The Elderly Revenue by Type (2021-2026)
- 8.2.2 North America Health Products for The Elderly Revenue by Type (2027-2032)
- 8.3 North America Health Products for The Elderly Revenue Share by Type (2021-2032)
- 8.4 North America Health Products for The Elderly Revenue by Application (2021-2032)
- 8.4.1 North America Health Products for The Elderly Revenue by Application (2021-2026)
- 8.4.2 North America Health Products for The Elderly Revenue by Application (2027-2032)
- 8.5 North America Health Products for The Elderly Revenue Share by Application (2021-2032)
- 8.6 North America Health Products for The Elderly Revenue by Country
- 8.6.1 North America Health Products for The Elderly Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Health Products for The Elderly Revenue by Country (2021-2026)
- 8.6.3 North America Health Products for The Elderly Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Health Products for The Elderly Revenue (2021-2032)
- 9.2 Europe Health Products for The Elderly Revenue by Type (2021-2032)
- 9.2.1 Europe Health Products for The Elderly Revenue by Type (2021-2026)
- 9.2.2 Europe Health Products for The Elderly Revenue by Type (2027-2032)
- 9.3 Europe Health Products for The Elderly Revenue Share by Type (2021-2032)
- 9.4 Europe Health Products for The Elderly Revenue by Application (2021-2032)
- 9.4.1 Europe Health Products for The Elderly Revenue by Application (2021-2026)
- 9.4.2 Europe Health Products for The Elderly Revenue by Application (2027-2032)
- 9.5 Europe Health Products for The Elderly Revenue Share by Application (2021-2032)
- 9.6 Europe Health Products for The Elderly Revenue by Country
- 9.6.1 Europe Health Products for The Elderly Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Health Products for The Elderly Revenue by Country (2021-2026)
- 9.6.3 Europe Health Products for The Elderly Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Health Products for The Elderly Revenue (2021-2032)
- 10.2 China Health Products for The Elderly Revenue by Type (2021-2032)
- 10.2.1 China Health Products for The Elderly Revenue by Type (2021-2026)
- 10.2.2 China Health Products for The Elderly Revenue by Type (2027-2032)
- 10.3 China Health Products for The Elderly Revenue Share by Type (2021-2032)
- 10.4 China Health Products for The Elderly Revenue by Application (2021-2032)
- 10.4.1 China Health Products for The Elderly Revenue by Application (2021-2026)
- 10.4.2 China Health Products for The Elderly Revenue by Application (2027-2032)
- 10.5 China Health Products for The Elderly Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Health Products for The Elderly Revenue (2021-2032)
- 11.2 Asia Health Products for The Elderly Revenue by Type (2021-2032)
- 11.2.1 Asia Health Products for The Elderly Revenue by Type (2021-2026)
- 11.2.2 Asia Health Products for The Elderly Revenue by Type (2027-2032)
- 11.3 Asia Health Products for The Elderly Revenue Share by Type (2021-2032)
- 11.4 Asia Health Products for The Elderly Revenue by Application (2021-2032)
- 11.4.1 Asia Health Products for The Elderly Revenue by Application (2021-2026)
- 11.4.2 Asia Health Products for The Elderly Revenue by Application (2027-2032)
- 11.5 Asia Health Products for The Elderly Revenue Share by Application (2021-2032)
- 11.6 Asia Health Products for The Elderly Revenue by Country
- 11.6.1 Asia Health Products for The Elderly Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Health Products for The Elderly Revenue by Country (2021-2026)
- 11.6.3 Asia Health Products for The Elderly Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Health Products for The Elderly Revenue (2021-2032)
- 12.2 SAMEA Health Products for The Elderly Revenue by Type (2021-2032)
- 12.2.1 SAMEA Health Products for The Elderly Revenue by Type (2021-2026)
- 12.2.2 SAMEA Health Products for The Elderly Revenue by Type (2027-2032)
- 12.3 SAMEA Health Products for The Elderly Revenue Share by Type (2021-2032)
- 12.4 SAMEA Health Products for The Elderly Revenue by Application (2021-2032)
- 12.4.1 SAMEA Health Products for The Elderly Revenue by Application (2021-2026)
- 12.4.2 SAMEA Health Products for The Elderly Revenue by Application (2027-2032)
- 12.5 SAMEA Health Products for The Elderly Revenue Share by Application (2021-2032)
- 12.6 SAMEA Health Products for The Elderly Revenue by Country
- 12.6.1 SAMEA Health Products for The Elderly Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Health Products for The Elderly Revenue by Country (2021-2026)
- 12.6.3 SAMEA Health Products for The Elderly Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst